William Blair downgrades Booz Allen, CACI International, Leidos, Parsons and General Dynamics on the heightened risk of ...

Insulet Corporation (NASDAQ:PODD) reported fourth-quarter adjusted EPS of $1.15, down from $1.40 a year ago but beating the ...

Research analysts at William Blair upped their Q1 2025 earnings per share (EPS) estimates for shares of Valmont Industries in ...

The U.S. Department of Defense has launched a massive review of consulting services contracts, with an eye toward making cuts ...

William Blair lifted their Q1 2025 earnings estimates for Watsco in a research report issued on Tuesday, February 18th. William Blair analyst R. Merkel now anticipates that the construction company ...

William Blair analyst Arjun Bhatia maintained a Buy rating on Radcom (RDCM – Research Report) today. The company’s shares opened today at ...

Fintel reports that on February 18, 2025, William Blair upgraded their outlook for Parsons (NYSE:PSN) from Market Perform to ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Repligen Corp (NASDAQ:RGEN) released its fourth-quarter adjusted EPS of 44 cents on Tuesday, down from 48 cents a year ago ...

Pediatrix Medical reported Q4 revenue of $502.36 million, surpassing estimates, with adjusted EPS of $0.51. The company ...

Founded by Josh Gerry who was most recently at LPL and with three decades of wealth industry experience, Chicago-based ...